SII To Launch Covavax For Children In Mid 2022: Adar Poonawalla
The Serum Institute of India CEO Adar Poonawalla announced to launch COVID-19 vaccine against children (3+). Addressing an event at SII, on December 14, Poonawalla said, Covavax is an Indian made version of the US-based Novavax. It is currently under trial and is showing excellent results on children. If successful, Covavax will be launched by mid-2022 in India, protecting kids against the COVID-19 virus.